FR2407930A1 - Nouvelles 4-quinolyl-guanidines, utiles notamment comme anti-inflammatoires, et leur procede de preparation - Google Patents

Nouvelles 4-quinolyl-guanidines, utiles notamment comme anti-inflammatoires, et leur procede de preparation

Info

Publication number
FR2407930A1
FR2407930A1 FR7831339A FR7831339A FR2407930A1 FR 2407930 A1 FR2407930 A1 FR 2407930A1 FR 7831339 A FR7831339 A FR 7831339A FR 7831339 A FR7831339 A FR 7831339A FR 2407930 A1 FR2407930 A1 FR 2407930A1
Authority
FR
France
Prior art keywords
methylcyten
unctyl
trifluoromethyl
methylcyl
alcoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7831339A
Other languages
English (en)
Other versions
FR2407930B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RECH APPLICATIONS THERAP
Original Assignee
RECH APPLICATIONS THERAP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RECH APPLICATIONS THERAP filed Critical RECH APPLICATIONS THERAP
Publication of FR2407930A1 publication Critical patent/FR2407930A1/fr
Application granted granted Critical
Publication of FR2407930B1 publication Critical patent/FR2407930B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)

Abstract

LES MEDICAMENTS SELON L'INVENTION CONSISTENT EN NOUVELLES 4-QUINOLYL-GUANIDINES DE FORMULE GENERALE: (CF DESSIN DANS BOPI) DANS LAQUELLE R REPRESENTE UN ATOME D'HYDROGENE OU D'HALOGENE OU UN GROUPE ALKYLE EN C-C, ALCOXY EN C-C, HYDROXY, TRIFLUOROMETHYLE OU PHENYLE; R REPRESENTE UN ATOME D'HYDROGENE OU D'HALOGENE OU UN GROUPE ALKYLE EN C-C, ALCOXY EN C-C, TRIFLUOROMETHYLE OU HYDROXY; R REPRESENTE UN GROUPE ALKYLE EN C-C, PAR EXEMPLE UN RADICAL METHYLE, ETHYLE, PROPYLE, ISOPROPYLE, BUTYLE, ISOBUTYLE OU TERBIOBUTYLE, OU L'UN DES RADICAUX PENTYLE, HEXYLE, HEPTYLE, OCTYLE, NONYLE, DECYLE, UNDECYLE, DODECYLE, ET OCTADECYLE ISOMERES, OU BIEN UN RADICAL CYCLOALKYLE EN C-C QUI PEUT EN OUTRE ETRE MONO- OU DI- SUBSTITUE PAR DES RESTES METHYLE OU ETHYLE, PAR EXEMPLE CYCLOPROPYLE, CYCLOBUTYLE, CYCLOPENTYLE, CYCLOHEXYLE OU METHYLCYCLOHEXYLE, OU PHENYLE OU PHENYLALKYLE EN C-C QUI PEUT ENCORE ETRE SUBSTITUE PAR DES HALOGENES OU DES GROUPES METHYLE, METHOXY, OU TRIFLUOROMETHYLE; ET R REPRESENTE UN RESTE HETEROCYCLIQUE A 5 OU 6CHAINONS CONTENANT AU MOINS UN ATOME D'AZOTE ET, FACULTATIVEMENT D'AUTRES ATOMES D'AZOTE, D'OXYGENE ETOU DE SOUFRE, LEDIT RESTE HETEROCYCLIQUE ETANT FACULTATIVEMENT SUBSTITUE PAR DES HALOGENES OU DES GROUPES ALKYLE EN C-C, ALCOXY EN C-C, CARBOXY, CARBALCOXY, TRIFLUOROMETHYLE, HYDROXY ETOU MERCAPTO; OU BIEN CE RESTE HETEROCYCLIQUE FORMANT PARTIE D'UN SYSTEME CYCLIQUE CONDENSE PLUS GRAND; ET LEURS SELS, COMPLEXES ET DERIVES ACYLES NON TOXIQUES ACCEPTABLES EN PHARMACIE. APPLICATIONS COMME ANTI-INFLAMMATOIRES, ANALGESIQUES OU ANTIPYRETIQUES, PAR VOIE ORALE, ENTERALE, PARENTERALE OU LOCALE, A DES DOSES JOURNALIERES D'ENVIRON 1 A 30MGKG.
FR7831339A 1977-11-07 1978-11-06 Nouvelles 4-quinolyl-guanidines, utiles notamment comme anti-inflammatoires, et leur procede de preparation Granted FR2407930A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB4616677 1977-11-07

Publications (2)

Publication Number Publication Date
FR2407930A1 true FR2407930A1 (fr) 1979-06-01
FR2407930B1 FR2407930B1 (fr) 1983-03-18

Family

ID=10440127

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7831339A Granted FR2407930A1 (fr) 1977-11-07 1978-11-06 Nouvelles 4-quinolyl-guanidines, utiles notamment comme anti-inflammatoires, et leur procede de preparation

Country Status (24)

Country Link
US (1) US4293549A (fr)
JP (1) JPS5473784A (fr)
AT (1) AT366368B (fr)
AU (1) AU517670B2 (fr)
BE (1) BE871807A (fr)
CA (1) CA1120929A (fr)
CH (1) CH645354A5 (fr)
DE (1) DE2847792A1 (fr)
DK (1) DK153950C (fr)
ES (1) ES474900A1 (fr)
FI (1) FI69463C (fr)
FR (1) FR2407930A1 (fr)
GR (1) GR65010B (fr)
IE (1) IE47458B1 (fr)
IT (1) IT1100075B (fr)
LU (1) LU80476A1 (fr)
NL (1) NL7811035A (fr)
NZ (1) NZ188770A (fr)
PH (1) PH16296A (fr)
PT (1) PT68750A (fr)
SE (1) SE446267B (fr)
SU (1) SU828967A3 (fr)
YU (1) YU41129B (fr)
ZA (1) ZA786175B (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6306846B1 (en) * 1972-05-31 2001-10-23 John R. J. Sorenson Anti-inflammatory and anti-ulcer compounds and process
IT1205640B (it) * 1983-04-06 1989-03-23 Yason Srl Nuovi composti ad attivita' antiinfiammatoria,procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
US4563460A (en) * 1984-01-13 1986-01-07 William H. Rorer, Inc. Quinoline and quinazoline derivatives for treating gastrointestinal motility dysfunctions
HU195487B (en) * 1985-06-04 1988-05-30 Egyt Gyogyszervegyeszeti Gyar Process for producing quinoline derivatives
EP0259085B1 (fr) * 1986-08-29 1991-08-21 Pfizer Inc. Guanidino-2 aryl-4 thiazole pour le traitement de l'ulcère peptique
US6100260A (en) * 1997-04-21 2000-08-08 Sumitomo Pharmaceutical Company, Limited Isoxazole derivatives
SI0928793T1 (en) * 1998-01-02 2002-10-31 F. Hoffmann-La Roche Ag Thiazole derivatives
US6410561B1 (en) * 1998-03-26 2002-06-25 Japan Tobacco Inc. Amide derivatives and nociceptin antagonists
CA2389773A1 (fr) * 1999-11-05 2001-05-10 Robert Glen Activateurs de la guanylate cyclase soluble
US7186725B2 (en) * 2003-01-03 2007-03-06 Genzyme Corporation Anti-inflammatory compositions and methods
JP4613157B2 (ja) * 2003-01-14 2011-01-12 サイトキネティクス・インコーポレーテッド 化合物、組成物および方法
GB0404434D0 (en) * 2004-02-27 2004-03-31 Novartis Ag Organic compounds
WO2007022964A2 (fr) * 2005-08-24 2007-03-01 Abbott Gmbh & Co. Kg Composes guanidine a substitution hetaryl et utilisation en tant que partenaires de liaison pour des recepteurs de 5-ht5
CN117677386A (zh) * 2021-07-23 2024-03-08 瓦伦塔有限责任公司 具有亲溶酶体和抗病毒活性的化合物

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB889262A (en) * 1959-07-03 1962-02-14 Ciba Ltd Quinoline compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB889282A (en) * 1957-05-07 1962-02-14 Air Reduction Preparation of hexafluorodiethyl ether and medicinal compositions containing it
US3159676A (en) * 1962-02-07 1964-12-01 Smith Kline French Lab Naphthyl containing guanidines
US3852293A (en) 1972-06-21 1974-12-03 Uniroyal Inc 4-phenyl-2-(3-pyridyl)-thiazole carboxamides
US4000279A (en) * 1974-10-29 1976-12-28 Armour Pharmaceutical Company Pharmaceutical preparations containing 5'-(8'-hydroxyquinolyl)guanidine compounds and methods of using same

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB889262A (en) * 1959-07-03 1962-02-14 Ciba Ltd Quinoline compounds

Also Published As

Publication number Publication date
AT366368B (de) 1982-04-13
SU828967A3 (ru) 1981-05-07
FR2407930B1 (fr) 1983-03-18
DE2847792C2 (fr) 1988-02-04
BE871807A (fr) 1979-05-07
CH645354A5 (de) 1984-09-28
SE446267B (sv) 1986-08-25
NL7811035A (nl) 1979-05-09
AU517670B2 (en) 1981-08-20
DK493378A (da) 1979-05-08
IT7829514A0 (it) 1978-11-07
GR65010B (en) 1980-06-12
JPS5473784A (en) 1979-06-13
AU4137678A (en) 1979-05-17
ES474900A1 (es) 1980-04-16
DK153950B (da) 1988-09-26
NZ188770A (en) 1984-07-31
CA1120929A (fr) 1982-03-30
SE7811457L (sv) 1979-05-08
FI69463B (fi) 1985-10-31
IT1100075B (it) 1985-09-28
PH16296A (en) 1983-09-05
US4293549A (en) 1981-10-06
DE2847792A1 (de) 1979-05-10
DK153950C (da) 1989-02-20
JPS6348873B2 (fr) 1988-09-30
FI69463C (fi) 1986-02-10
ZA786175B (en) 1979-10-31
YU257578A (en) 1983-01-21
LU80476A1 (fr) 1979-06-15
IE47458B1 (en) 1984-03-21
FI783327A (fi) 1979-05-08
PT68750A (en) 1978-12-01
IE782084L (en) 1979-05-07
ATA773278A (de) 1981-08-15
YU41129B (en) 1986-12-31

Similar Documents

Publication Publication Date Title
FR2407930A1 (fr) Nouvelles 4-quinolyl-guanidines, utiles notamment comme anti-inflammatoires, et leur procede de preparation
IT1314184B1 (it) Composizioni farmaceutiche per la terapia di condizioni di stressossidativo
SE8107274L (sv) 1-sulfo-2-oxazetidinderivat, forfarande for framstellning derav och faramceutisk komposition innehallande desamma
FR2453853A1 (fr) Nouveaux derives d'o-(4-diphenylmethylpiperidino)-alcanophenones utiles notamment comme antihistaminiques, et leur procede de preparation
PT84229A (en) Process for preparing novel phenolic thioethers useful as inhibitors of 5-lipoxygenase
DK0694545T3 (da) Substituerede dibenzoxazepinforbindelser, farmaceutiske sammensætninger og anvendelsesmetoder
KR890005031A (ko) L-도파유도체 또는 그의 산부가염, 그의 제조방법 및 그의 용도
ES2051854T3 (es) Procedimiento para preparar derivados del acido hidroxamico con propiedades anti-inflamatorias.
NL8204126A (nl) Werkwijze voor het bereiden van een farmaceutisch preparaat met locaal-anesthetische werking dat een dialylamino-2',6'acetoxylidide en/of een farmaceutisch aanvaardbaar zout daarvan bevat, alsmede de onder toepassing van deze werkwijze verkregen gevormde farmaceutische preparaten en werkwijze voor het bereiden van dialkylamino-2',6'acetoxylididen en de farmaceutisch aanvaardbare zouten daarvan.
CA2412932A1 (fr) Derives de pleuromutiline presentant une activite antibacterienne
CO4700291A1 (es) Compuestos quimicos
RU94039539A (ru) N,n'-замещенные имидокарбонимидные диамиды, получаемые из гидроксиламинов, имеющие антимикробную и антипаразитическую активность, профилактическая композиция, композиция для снижения уровня инфекций
GB1481813A (en) Substituted thiazolinylidenyl ketones and their pharmaceutical compositions
ES8704153A1 (es) Un procedimiento para preparar derivados de pirimidina
HU9200335D0 (en) Medical products with human interleukin-2 content
GB1113391A (en) Biologically active dithiosemicarbazones
TNSN93107A1 (fr) Derives de piperidine, leur preparation et leur application en therapeutique
GB1031425A (en) New aralkylamines and their preparation
BR8105437A (pt) Processo para a preparacao de derivados de azolilaquila, composicoes fungicidas, processos para combater fungos e para a preparacao das composicoes
EA200000389A3 (ru) Новые замещенные пиридины или пиперидины, способ их получения и содержащие их фармацевтические композиции
ES2059348T3 (es) Composicion farmaceutica para el tratamiento de cataratas.
KR890003692A (ko) 1.2.5.6- 테트라히드로피리딘-3-카르복스알데히드의 옥심유도체, 이들의 제조방법, 약제로서의 이들의 용도 및 이들을 함유하는 조성물
ES2098370T3 (es) Derivado del acido epoxisuccinamico.
KR970704723A (ko) 항염증제로서 유용한 디히드로벤조푸란 및 관련 화합물(dihydrobenzofuran and related compounds useful as anti-inflammatory agents)
ZA842423B (en) Compounds with antiinflammatory activity,process for preparation thereof and pharmaceutical compositions therefrom

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse